Sharemaestro Newsreel

Dentsply Sirona (XRAY): Southpoint reports 7M-share, 3.5% ownership in 13G/A

Southpoint Master Fund and its affiliates, including John S. Clark II, have reported a beneficial ownership of 7,000,000 shares, representing a 3.5% stake in Dentsply Sirona Inc. (XRAY). This disclosure was made in an amended Schedule 13G/A filing, indicating shared voting and dispositive power …

12 New Hires Receive 51,947 Scholar Rock Equity Awards

Scholar Rock (NASDAQ: SRRK) announced that it granted inducement equity awards totaling 51,947 shares of common stock to twelve new employees. These awards, which include both stock options and restricted stock units, are part of the company's 2022 Inducement Equity Plan, designed to attract …

Erasca (ERAS) insiders report 10.4% and 5.6% ownership stakes

Erasca, Inc. has filed an amended passive investment disclosure (SCHEDULE 13G/A) detailing updated insider ownership. Jonathan E. Lim beneficially owns 10.4% of the common stock, while Conyee T. Lim holds a 5.6% beneficial stake. These figures are based on 349,762,035 shares outstanding as of …

LeonaBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC (KSF) is reminding investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who incurred substantial losses to file lead plaintiff applications by September 22, 2026. This securities class action lawsuit alleges that Procept and its executives failed to disclose material information …

Paradigm BioCapital reports 6.1% Viridian (VRDN) stake and 5.3% held by offshore fund

Paradigm BioCapital Advisors LP, its general partner, and Senai Asefaw M.D. have reported a beneficial ownership of 6,723,788 shares of Viridian Therapeutics (VRDN) common stock, representing 6.1% of the outstanding class as of June 30, 2026. Separately, Paradigm BioCapital International Fund Ltd. directly holds …

InflaRx (IFRX) investors report 15.6% and 12.5% stakes in updated 13G/A

Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen have filed an updated Schedule 13G/A, reporting significant beneficial ownership in InflaRx N.V. Montanova Capital and Aaron Cowen each report a 15.6% stake, while Averill Master Fund, Ltd. holds 12.5% of the common shares. …

Cellectar Biosciences (CLRB): Caligan Partners reports 5.9% ownership stake

Caligan Partners LP and David Johnson have reported a beneficial ownership stake of 5.9% in Cellectar Biosciences (CLRB), amounting to 469,998 shares. This ownership is held through Caligan-managed funds and accounts, with shared voting and dispositive power. The percentage is based on 7,991,812 shares …

Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership

ARCH Venture Fund XII and related entities have disclosed a 5.3% beneficial ownership stake in Parabilis Medicines (PBLS), amounting to 6,412,780 shares of common stock. This Schedule 13G filing indicates a passive investment, with ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, …

Senti Biosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Senti Biosciences Holdings, Inc. reported its earnings results for the second quarter and six months ended June 30, 2026. For the second quarter, the company's net loss decreased to USD 12.75 million from USD 14.73 million a year prior, with basic and diluted loss …

Vestal Point Capital (IBIO) discloses 4.0M-share iBio position including warrants

Vestal Point Capital, LP and Ryan Wilder have reported an updated beneficial ownership of 4,025,000 shares of iBio, Inc. common stock, which includes 1,425,000 shares issuable from warrants. This holding represents a 7.9% stake in iBio, calculated based on 49,678,561 shares outstanding as of …

Rubric Capital discloses 3.9M-share Enovis (ENOV) position in Schedule 13G

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, disclosing beneficial ownership of 3,900,000 shares of Enovis Corporation (ENOV) common stock. This position represents 6.78% of the company's outstanding shares, based on 57,562,603 shares as of May 1, 2026. Both …

Pyxis Oncology (PYXS) CEO receives 250,956-share performance-based option grant

Pyxis Oncology's Interim CEO, Thomas Civik, has been granted a performance-based stock option for 250,956 shares, which vested on August 12, 2026. The option has an exercise price of $1.49 per share and an expiration date of February 3, 2036. This vesting occurred after …

Belite Bio (BLTE) Could Be 21% Undervalued On FDA Priority Review News

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Belite Bio (BLTE) is back in focus after the FDA accepted its New Drug Application for tinlarebant with Priority Review, a key regulatory step that …

Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales

Carlsmed Inc. (CARL) has filed a shelf registration to offer up to $250 million in common stock, preferred stock, debt securities, warrants, and units. This filing allows the medical technology company to access capital markets for future funding, with specific terms for each issuance …

Northland Securities Maintains Nephros(NEPH.US) With Hold Rating, Raises Target Price to $4.75

Northland Securities has reiterated its Hold rating on Nephros (NEPH.US) but raised the price target to $4.75. This adjustment indicates a slightly more optimistic outlook on the company's future stock performance by the firm.

Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP announces a securities fraud class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR). Investors who purchased CAPR securities between December 17, 2025, and July 26, 2026, have until September 28, 2026, to seek lead plaintiff status. The lawsuit …

Is Centene (CNC) Fairly Valued After Raised Outlook And Its Debt Redemption Plan?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Recent commentary on Centene (CNC) has focused on a fresh debt redemption plan and higher expectations for revenue and earnings, which together are shaping how …

Intuitive Surgical Inc. stock underperforms Friday when compared to competitors

Intuitive Surgical Inc. (ISRG) shares fell 1.68% to $394.51 on Friday, underperforming the broader market as the S&P 500 and Dow Jones also experienced slight declines. The company's stock closed 34.67% below its 52-week high, which was set on January 7th. This report highlights …

Vivos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Actuate Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Precipio, Inc. (PRPO) grows Q2 2026 revenue 24% amid going concern warning

Edgewise Therapeutics (EWTX): Baker Bros. discloses 3.4% ownership in Schedule 13G/A

Valneva (NASDAQ:VALN) Issues Earnings Results, Misses Expectations By $0.17 EPS

The Technical Signals Behind (CERT) That Institutions Follow

This article from Stock Traders Daily analyzes Certara Inc. (NASDAQ: CERT) using AI models to provide technical signals for institutional trading strategies. It highlights mixed sentiment, suggesting choppy conditions, and outlines position, momentum, and risk hedging strategies with specific entry, target, and stop-loss levels. …

Medline Inc. Class A Common Stock (NASDAQ: MDLN) Stock Price, News & Analysis

Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates

Why (ASMB) Price Action Is Critical for Tactical Trading

This article analyzes the price action of Assembly Biosciences Inc. (ASMB), highlighting a mid-channel oscillation pattern and a strong risk-reward short setup. It presents three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis to …

Rubric Capital discloses 9.83% MeiraGTx (MGTX) position totaling 9.1M shares

Rubric Capital Management LP and David Rosen have reported a beneficial ownership of 9.83% in MeiraGTx Holdings plc, amounting to 9,100,000 Ordinary Shares. This disclosure was made in an amended Schedule 13G filing, indicating shared voting and dispositive power over these shares, which are …

Bio-Techne Corp (TECH) Stock News Today

Rubric Capital discloses 5.83% MannKind Corporation (MNKD) stake

Rubric Capital Management LP and David Rosen have reported a passive ownership stake of 5.83% in MannKind Corporation (MNKD), holding 18,000,000 shares with shared voting and dispositive power. This percentage is based on 308,950,166 shares outstanding as of April 24, 2026. Rubric Capital Master …

Prestige Consumer Healthcare's Jeffrey Zerillo to Retire as SVP, Operations

Prestige Consumer Healthcare announced that Jeffrey Zerillo, their Senior Vice President of Operations, will be retiring effective August 14, 2026. This information is based on an SEC filing (8-K) by Prestige Consumer Healthcare Inc. (PBH).

New owner secures mystery tenant for Everett plant shelved by Pfizer

A California developer has purchased the unfinished $350 million biomanufacturing facility in Everett that Pfizer halted after acquiring Seagen in 2023. The new owner has also secured a tenant for the plant, though the tenant's identity remains undisclosed. This development provides a future for …

Four Oculis directors' restricted stock units vest in Aug. 13 notifications

Oculis (NASDAQ: OCS) announced that restricted stock units (RSUs) granted to directors Anthony Rosenberg, Christina Ackermann, Arshad Khanani, and Robert Warner vested on August 13, 2026. The company published notifications regarding these vesting and settlement transactions. While the announcement confirms the RSU vests for …

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis Holding AG has published notifications regarding transactions by persons discharging managerial responsibilities. These notifications relate to the vesting and settlement of Restricted Stock Units (RSUs) previously granted to company directors. The listed individuals include Anthony Rosenberg, Christina Ackermann, Arshad Khanani, and Robert Warner, …

Lantern Pharma Reports 46.2% Wider Q2 2026 Loss at -$0.57/Share